Predict your next investment

Angel Investor (Group)
emergentgrowth.com

See what CB Insights has to offer

Investments

29

Portfolio Exits

1

Funds

2

About Emergent Growth Fund

The Emergent Growth Funds are member-managed angel funds that focus on early stage companies. The members of the Emergent Growth funds are successful business people and investors.Although Emergent does not invest solely in companies or technologies that originate from the University of Florida or the surrounding geographic area, it is most attentive to those that do.The size of an investment made by Emergent can range from a low of $100,000, to more than $500,000 with add-on investments from our individual members. An average investment is likely in the range of $200,000 to $500,000. By investing side-by-side with one or more partner angel funds, Emergent Growth Fund can invest up to $2 million in an opportunity.

Emergent Growth Fund Headquarter Location

101 SE 2nd Place Suite 201C

Gainesville, Florida, 32601,

United States

(352) 335-3021

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Emergent Growth Fund Investments

29 Investments

Emergent Growth Fund has made 29 investments. Their latest investment was in Arbovax as part of their Series C on October 10, 2011.

CBI Logo

Emergent Growth Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/14/2011

Series C

Arbovax

$1.73M

No

10/12/2011

Debt

Bacch Labs

$0.74M

No

2/18/2011

Series A

Bacch Labs

$1.56M

No

12/8/2010

Series B

Subscribe to see more

$99M

Subscribe to see more

0

7/14/2010

Angel - III

Subscribe to see more

$99M

Subscribe to see more

0

Date

10/14/2011

10/12/2011

2/18/2011

12/8/2010

7/14/2010

Round

Series C

Debt

Series A

Series B

Angel - III

Company

Arbovax

Bacch Labs

Bacch Labs

Subscribe to see more

Subscribe to see more

Amount

$1.73M

$0.74M

$1.56M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

Emergent Growth Fund Portfolio Exits

1 Portfolio Exit

Emergent Growth Fund has 1 portfolio exit. Their latest portfolio exit was Clinipace on April 28, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/28/2021

Merger

$99M

4

Date

4/28/2021

Exit

Merger

Companies

Valuation

$99M

Acquirer

Sources

4

Emergent Growth Fund Fund History

2 Fund Histories

Emergent Growth Fund has 2 funds, including EGFII.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/10/2008

EGFII

Early-Stage Venture Capital

Closed

$3M

1

12/31/2003

EGFI

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

7/10/2008

12/31/2003

Fund

EGFII

EGFI

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

$3M

$99M

Sources

1

10

Emergent Growth Fund Team

2 Team Members

Emergent Growth Fund has 2 team members, including current Founder, Russ Donda.

Name

Work History

Title

Status

Russ Donda

BioEnterprise, HyGreen, Synogen Development Group, ViewRay, and RTI Surgical

Founder

Current

Eric Buffkin Jr.

Founder

Current

Name

Russ Donda

Eric Buffkin Jr.

Work History

BioEnterprise, HyGreen, Synogen Development Group, ViewRay, and RTI Surgical

Title

Founder

Founder

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.